Cargando…

Circulating Vascular Endothelial Growth Factor (VEGF) Levels in Advanced Stage Cancer Patients Compared to Normal Controls and Diabetes Mellitus Patients with Critical Ischemia

Anti-angiogenic therapy is emerging as a valuable tool in the treatment of patients with cancer. As VEGF is a central target in anti-angiogenic therapy, its levels in the circulation might be relevant in selecting tumor types or patients likely to respond to this treatment. Additional VEGF has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kusumanto, Yoka H., Meijer, Coby, Dam, Wendy, Mulder, Nanno H., Hospers, Geke A.P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Libertas Academica 2007
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3155238/ https://www.ncbi.nlm.nih.gov/pubmed/21901067

Ejemplares similares

A patient with metastatic melanoma presenting with gastrointestinal perforation after dacarbazine infusion: a case report
por: Oosting, Sjoukje F, et al.
Publicado: (2010)

Retrospective Denial as A Coping Method
por: Siemerink, Ester J. M., et al.
Publicado: (2011)

Double VEGF/HGF Gene Therapy in Critical Limb Ischemia Complicated by Diabetes Mellitus
por: Barć, Piotr, et al.
Publicado: (2020)

Gene specific overwriting of epigenetic signatures to modulate the expression of selected tumor-promoting genes in cancer
por: Falahi, Fahimeh, et al.
Publicado: (2013)

Preoperative Chemoradiotherapy with Capecitabine and Oxaliplatin in Locally Advanced Rectal Cancer. A Phase I–II Multicenter Study of the Dutch Colorectal Cancer Group
por: Hospers, Geke A., et al.
Publicado: (2007)

Reirradiation + hyperthermia for recurrent breast cancer en cuirasse
por: Oldenborg, Sabine, et al.
Publicado: (2017)

(18)F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study
por: Nienhuis, Pieter H., et al.
Publicado: (2022)

Rapid BRAF mutation tests in patients with advanced melanoma: comparison of immunohistochemistry, Droplet Digital PCR, and the Idylla Mutation Platform
por: Bisschop, Cornelis, et al.
Publicado: (2018)

The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
por: Meijer, C., et al.
Publicado: (1990)

Image Quality and Interpretation of [(18)F]-FES-PET: Is There any Effect of Food Intake?
por: Boers, Jorianne, et al.
Publicado: (2020)

Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and Circulating Microparticles in Type 1 Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2019)

Enhanced expression of PD-1 and other activation markers by CD4+ T cells of young but not old patients with metastatic melanoma
por: van den Brom, Rob R. H., et al.
Publicado: (2018)

The Prognostic Value of Circulating VEGF-A Level in Patients With Hepatocellular Cancer
por: Lacin, Sahin, et al.
Publicado: (2020)

Preoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma
por: Faut, Marloes, et al.
Publicado: (2018)

Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible
por: Dijkstra, Esmée A., et al.
Publicado: (2021)

HIF-1 mediated upregulation of VEGF and VEGF-R in systemic sclerosis (SSc): Imbalance with angiostatic factors suggests VEGF as a novel option for the treatment of ischemia in patients with SSc
por: Distler, O, et al.
Publicado: (2002)

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer
por: Falahi, Fahimeh, et al.
Publicado: (2014)

Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins
por: DePrimo, Samuel E, et al.
Publicado: (2007)

In Potential Stroke Patients on Warfarin, the International Normalized Ratio Predicts Ischemia
por: Cao, Cathy, et al.
Publicado: (2017)

OTHR-01. Unmet clinical needs in patients with brain metastases in the current treatment era
por: Eggen, Annemarie C, et al.
Publicado: (2021)

Circulating Endothelial Microparticles in Diabetes Mellitus
por: Tramontano, A. F., et al.
Publicado: (2010)

The Presence of VEGF Receptors on the Luminal Surface of Endothelial Cells Affects VEGF Distribution and VEGF Signaling
por: Stefanini, Marianne O., et al.
Publicado: (2009)

Circulating inflammatory proteins associate with response to immune checkpoint inhibition therapy in patients with advanced melanoma
por: Rossi, Niccolò, et al.
Publicado: (2022)

Anti-tumor treatment and healthcare consumption near death in the era of novel treatment options for patients with melanoma brain metastases
por: Eggen, Annemarie C., et al.
Publicado: (2022)

Plasma levels of soluble VEGF receptor isoforms, circulating pterins and VEGF system SNPs as prognostic biomarkers in patients with acute coronary syndromes
por: Marks, Edward C. A., et al.
Publicado: (2018)

Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis
por: Marino, Franca, et al.
Publicado: (2015)

Circulating Endothelial Microparticles and Aortic Stiffness in Patients with Type 2 Diabetes Mellitus
por: Dec-Gilowska, Malgorzata, et al.
Publicado: (2019)

Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
por: Boonstra, Pieter A., et al.
Publicado: (2020)

Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels.
por: Yamamoto, S., et al.
Publicado: (1997)

Role of circulating CD14++CD16(+) monocytes and VEGF-B186 in formation of collateral circulation in patients with hyperacute AMI
por: Zhang, He, et al.
Publicado: (2023)

Correction: Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis
por: Marino, Franca, et al.
Publicado: (2017)

Circulating VEGF As a Biological Marker in Patients with Rheumatoid Arthritis? Preanalytical and Biological Variability in Healthy Persons and in Patients
por: Hetland, Merete Lund, et al.
Publicado: (2008)

The formation and removal of cisplatin (CDDP) induced DNA adducts in a CDDP sensitive and resistant human small cell lung carcinoma (HSCLC) cell line.
por: Hospers, G. A., et al.
Publicado: (1990)

VEGF-B-induced vascular growth leads to metabolic reprogramming and ischemia resistance in the heart
por: Kivelä, Riikka, et al.
Publicado: (2014)

Circulating Biomarkers of Endothelial Dysfunction and Inflammation in Predicting Clinical Outcomes in Diabetic Patients with Critical Limb Ischemia
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2022)

Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study
por: Engbersen, Richard, et al.
Publicado: (2012)

Circulating Total Glutathione in Normal Tension Glaucoma Patients: Comparison with Normal Control Subjects
por: Park, Myoung Hee, et al.
Publicado: (2012)

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab
por: Marisi, Giorgia, et al.
Publicado: (2017)

Regenerative repair of Pifithrin-α in cerebral ischemia via VEGF dependent manner
por: Zhang, Ping, et al.
Publicado: (2016)

Branch Retinal Vein Occlusion, Macular Ischemia, and Intravitreal Anti-VEGF Therapy
por: Bertelmann, Thomas, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_1icmq8svv0v39co4np184el3fk